Pirandamine ( AY-23,713) is a tricyclic derivative which acts as a selective serotonin reuptake inhibitor (SSRI). It was investigated in the 1970s as a potential antidepressant but clinical development was not commenced and it was never marketed. Pirandamine is structurally related to tandamine, which, in contrast, is a selective norepinephrine reuptake inhibitor.
Synthesis
Pirandamine can be synthesized starting from 1-indanone.
[I. Jirkovsky, L. G. Humber and R. Noureldin,Eur. J. Med. Chem., 11, 571 (1976).] The Reformatsky reaction between 1-indanone (
1) and ethyl bromoacetate in the presence of zinc gives ethyl 2-(1-hydroxy-2,3-dihydroinden-1-yl)acetate (
2). The reduction of the ester with ester with lithium aluminum hydride (LiAlH
4) gives 1-(2-hydroxyethyl)-2,3-dihydroinden-1-ol (
3). Acid-catalyzed dehydration then leads to indene-3-ethanol (
4). Acid-catalyzed condensation with ethyl acetoacetate then gives (
5). The
saponification of the ester then gives the corresponding acid. The reaction of this with ethyl chloroformate gives a mixed anhydride, and further reaction of this with
dimethylamine then leads to the amide (
6). Reduction with lithium aluminium hydride completes the synthesis of pirandamine (
7).
See also